Molecular epidemiology of Candida albicans and Candida glabrata strains isolated from intensive care unit patients in Poland

Memorias do Instituto Oswaldo Cruz

Volumn 109, Issue 4, 2014, Pages 436-441

  Paluchowska, Paulina ^a   Tokarczyk, Marianna ^a   Bogusz, Bozena ^b   Skiba, Iwona ^a   Budak, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Ludwik Rydygier Specialized Hospital   (Poland)

Author keywords

Candida albicans; Candida glabrata; Epidemiology; Genotyping; RAPD PCR

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA; PRIMER DNA;

ADULT; AGED; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; INTENSIVE CARE UNIT; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; POLAND; RANDOM AMPLIFIED POLYMORPHIC DNA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; DNA PRIMERS; DNA, FUNGAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; POLAND; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; YOUNG ADULT;

EID: 84904328386     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276140099     Document Type: Article

References (33)

1. Abbes S, Amouri I, Sellami H, Sellami A, Makni F, Ayadi A 2010. A review of molecular techniques to type Candida glabrata isolates. Mycoses 53: 463-467.
2. Arendrup MC 2010. Epidemiology of invasive candidiasis. Curr Opin Crit Care 16: 445-452.
3. Bacelo KL, da Costa KR, Ferreira JC, Candido RC 2010. Biotype stability of Candida albicans isolates after culture storage determined by randomly amplified polymorphic DNA and phenotypical methods. Mycoses 53: 468-474.
4. Ben Abdeljelil J, Saghrouni F, Emira N, Valentin-Gomez E, Chatti N, Boukadida J, Ben Saïd M, Agudo LDC 2011. Molecular typing of Candida albicans isolates from patients and health care workers in a neonatal intensive care unit. J Appl Microbiol 111: 1235-1249.
5. Bonfim-Mendonça PS, Fiorini A, Shinobu-Mesquita CS, Baeza LC, Fernandez MA, Svidzinski TI 2013. Molecular typing of Candida albicans isolates from hospitalized patients. Rev Inst Med Trop Sao Paulo 55: 385-391.
6. Brillowska-Dabrowska A, Bergmann O, Jensen IM, Jarløv JO, Arendrup MC 2010. Typing of Candida isolates from patients with invasive infection and concomitant colonization. Scand J Infect Dis 42: 109-113.
7. CLSI - Clinical and Laboratory Standards Institute 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts - approved standard, 3rd ed., CLSI M27-A3, Wayne, 13 pp.
8. da Costa KR, Ferreira JC, Lavrador MA, Baruffi MD, Candido RC 2012. Virulence attributes and genetic variability of oral Candida albicans and Candida tropicalis isolates. Mycoses 55: e97-e105.
9. Ergon MC, Gülay Z 2005. Molecular epidemiology of Candida species isolated from urine at an intensive care unit. Mycoses 48: 126-131.
10. Hunter PR, Gaston MA 1988. Numerical index of the discriminatory ability of typing systems an application of Simpson's index of diversity. J Clin Microbiol 26: 2465-2466.
11. Karaman M, Firinci F, Karaman O, Uzuner N, Bahar IH 2013. Longterm oropharyngeal colonization by C. albicans in children with cystic fibrosis. Yeast 30: 429-436.
12. Krasnodebska-Szponder B, Szymaniak L, Wojciechowska-Koszko I, Mnichowska M, Michalska-Krzanowska G, Giedrys-Kalemba S 2005. Species and genetic diversity of Candida genus fungi isolated from respiratory tract of intensive care unit patients. Med Mycol 12: 93-98.
13. Krawczyk B, Leibner-Ciszak J, Mielech A, Nowak M, Kur J 2009. PCR melting profile (PCR MP) - a new tool for differentiation of Candida albicans strains. BMC Infect Dis 9: 177.
14. Lass-Flörl C 2009. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52: 197-205.
15. Lian C, Zhao J, Zhang Z, Liu W 2004. Genotype of Candida species associated with different conditions of vulvovaginal candidosis. Mycoses 47: 495-502.
16. Marol S, Yücesoy M 2008. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses 51: 40-49.
17. Morace G, Borghi E 2010. Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol 76: 950-956.
18. Müller J, Kappe R, Jaeger R, Kubitza D 1986. Pathogen identification in indigenous deep mycoses, La Roche, Basel, 32 pp.
19. Muthig M, Hebestreit A, Ziegler U, Seidler M, Müller FM 2010. Persistence of Candida species in the respiratory tract of cystic fibrosis patients. Med Mycol 48: 56-63.
20. Nawrot U, Pajaczkowska M, Fleischer M, Przondo-Mordarska H, Samet A, Piasecka-Pazik D, Komarnicka J, Sulik-Tyszka B, Swoboda-Kopeć E, Cieślik J, Mikucka A, Gospodarek E, Ozorowski T, Mól A, Tryniszewska E, Kłosowska W, Krawczyk M, Golec K, Szymaniak L, Giedrys-Kalemba S, Bilska I, Prawda-Zołotar J, Juszczyk- Grudzińska M, Wróblewska M, Burdynowski K 2013. Candidaemia in Polish hospitals - a multicentre survey. Mycoses 56: 576-581.
21. Noumi E, Snoussi M, Saghrouni F, Ben Said M, Del Castillo L, Valentin E, Bakhrouf A 2009. Molecular typing of clinical Candida strains using random amplified polymorphic DNA and contourclamped homogenous electric fields electrophoresis. J Appl Microbiol 107: 1991-2000.
22. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M 2011. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob Agents Chemother 55: 561-566.
23. Pinto PM, Resende MA, Koga-Ito CY, Tendler M 2004. Genetic variability analysis among clinical Candida spp isolates using random amplified polymorphic DNA. Mem Inst Oswaldo Cruz 99: 147-152.
24. Robert F, Lebreton F, Bougnoux ME, Paugam A, Wassermann D, Schlotterer M, Tourte-Schaefer C, Dupouy-Camet J 1995. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol 33: 2366-2371.
25. Rodrigues CF, Silva S, Henriques M 2013. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis 33: 673-688.
26. Saghrouni F, Ben Abdeljelil J, Boukadida J, Ben Said M 2013. Molecular methods for strain typing of Candida albicans: a review. J Appl Microbiol 114: 1559-1574.
27. Soll DR 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 13: 332-370.
28. Szweda P, Gucwa K, Naumiuk L, Romanowska E, Dzierzanowska- Fangrat K 2013. Evaluation of possibilities of genotyping of Candida glabrata clinical isolates with RAPD-PCR method and microsatellite analysis. Scientific Journal of Microbiology 2: 194-200.
29. Taverna CG, Bosco-Borgeat ME, Murisengo OA, Davel G, Boité MC, Cupolillo E, Canteros CE 2013. Comparative analyses of classical phenotypic method and ribosomal RNA gene sequencing for identification of medically relevant Candida species. Mem Inst Oswaldo Cruz 108: 178-185.
30. Trojanowska D, Zwolinska-Wcislo M, Tokarczyk M, Kosowski K, Mach T, Budak A 2010. The role of Candida in inflammatory bowel disease. Estimation of transmission of C. albicans fungi in gastrointestinal tract based on genetic affinity between strains. Med Sci Monit 16: CR451-CR457.
31. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323-2329.
32. Vrioni G, Matsiota-Bernard P 2001. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect 42: 50-56.
33. Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied-Reouven A, Regev-Yochay G, Pitlik SD, Keller N 2005. Characteristics of candidaemia with Candida- albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 61: 146-154.